Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Aceragen, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −13 vs. Q4 2022
- Shares held
- 168.1K
- −22.2K (−11.7%) vs. Q4 2022Converted for a 1-for-17 split
- Total value
- $384.8K
- −$744.9K (−65.9%) vs. Q4 2022
- New holders
- 0
- 4 more added
- Sold out
- 13
- 13 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 3 | $0 |
| Q1 2024 | 3 | $0 |
| Q4 2023 | 3 | $0 |
| Q3 2023 | 3 | $22 |
| Q2 2023 | 20 | $269.5K |
| Q1 2023 | 19 | $384.8K |
| Q4 2022 | 32 | $1.13M |
| Q3 2022 | 34 | $1.30M |
| Q2 2022 | 33 | $1.65M |
| Q1 2022 | 31 | $1.86M |
| Q4 2021 | 34 | $2.42M |
| Q3 2021 | 47 | $6.39M |
| Q2 2021 | 48 | $7.60M |
| Q1 2021 | 57 | $12.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Aceragen, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 76,058 | $174.2K | 0.00% | +1,484+2.0% | AddedConverted for a 1-for-17 split |
| BlackRock Inc. | 25,214 | $57.7K | 0.00% | −636−2.5% | ReducedConverted for a 1-for-17 split |
| Geode Capital Management, LLC | 23,342 | $53.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-17 split |
| State Street Corp | 11,653 | $26.7K | 0.00% | +5,197+80.5% | AddedConverted for a 1-for-17 split |
| Credit Agricole S A | 11,521 | $26.4K | 0.00% | −244−2.1% | ReducedConverted for a 1-for-17 split |
| Hollencrest Capital Management | 7,587 | $17.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-17 split |
| Tower Research Capital LLC (TRC) | 6,155 | $14.0K | 0.00% | +4,858+374.5% | AddedConverted for a 1-for-17 split |
| Morgan Stanley | 4,855 | $11.1K | 0.00% | −1,350−21.8% | ReducedConverted for a 1-for-17 split |
| Group One Trading, L.P. | 1,243 | $2.85K | 0.00% | −1,341−51.9% | ReducedConverted for a 1-for-17 split |
| The PNC Financial Services Group, Inc. | 191 | $437 | 0.00% | −12−5.9% | ReducedConverted for a 1-for-17 split |
| UBS Group AG | 64 | $147 | 0.00% | −3,887−98.4% | ReducedConverted for a 1-for-17 split |
| Bank of America Corp | 58 | $133 | 0.00% | −7−10.5% | ReducedConverted for a 1-for-17 split |
| Parallel Advisors, LLC | 58 | $133 | 0.00% | −1−1.4% | ReducedConverted for a 1-for-17 split |
| Wells Fargo & Company | 35 | $80 | 0.00% | +12+52.6% | AddedConverted for a 1-for-17 split |
| Signaturefd, LLC | 11 | $25 | 0.00% | −0−3.1% | ReducedConverted for a 1-for-17 split |
| FMR LLC | 6 | $14 | 0.00% | −1−8.1% | ReducedConverted for a 1-for-17 split |
| NewSquare Capital LLC | 4 | $9 | 0.00% | −1−15.0% | ReducedConverted for a 1-for-17 split |
| Advisor Group Holdings, Inc. | 1 | $2 | 0.00% | −1−43.3% | ReducedConverted for a 1-for-17 split |
| JPMorgan Chase & Co | 10 | $0 | 0.00% | −2−15.0% | ReducedConverted for a 1-for-17 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −5,142−100.0% | Sold outConverted for a 1-for-17 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −4,369−100.0% | Sold outConverted for a 1-for-17 split |
| ABG Innovation Capital Partners III GP Ltd | 0 | $0 | 0.00% | −3,309−100.0% | Sold outConverted for a 1-for-17 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −2,960−100.0% | Sold outConverted for a 1-for-17 split |
| Johnson Investment Counsel Inc | 0 | $0 | 0.00% | −2,478−100.0% | Sold outConverted for a 1-for-17 split |
| Wade G W & Inc | 0 | $0 | 0.00% | −2,059−100.0% | Sold outConverted for a 1-for-17 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −1,865−100.0% | Sold outConverted for a 1-for-17 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,135−100.0% | Sold outConverted for a 1-for-17 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −864−100.0% | Sold outConverted for a 1-for-17 split |
| Mariner, LLC | 0 | $0 | 0.00% | −724−100.0% | Sold outConverted for a 1-for-17 split |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −636−100.0% | Sold outConverted for a 1-for-17 split |
| Ropes Wealth Advisors LLC | 0 | $0 | 0.00% | −601−100.0% | Sold outConverted for a 1-for-17 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −134−100.0% | Sold outConverted for a 1-for-17 split |